PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation-Reference-Cited by-同舟云学术

PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation

Published:2018-02-26 Issue:4 Volume:7 Page:1285-1296
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Mao Yize¹²,Huang Xin¹²,Shuang Zeyu¹³,Lin Guohe¹⁴,Wang Jun¹²⁵,Duan Fangting¹⁴,Chen Jianlin¹²,Li Shengping¹²⁴^ORCID

Affiliation:

1. State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Sun Yat-sen University Cancer Center; Guangzhou 510060 China

2. Department of Hepatobiliary Oncology; Sun Yat-sen University Cancer Center; Guangzhou 510060 China

3. Department of Breast Oncology; Sun Yat-sen University Cancer Center; Guangzhou 510060 China

4. Department of Experimental Research; Sun Yat-sen University Cancer Center; Guangzhou 510060 China

5. Department of Ultrasound; Sun Yat-sen University Cancer Center; Guangzhou 510060 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1318/fullpdf

Reference41 articles.

1. Incidence and mortality trends for biliary tract cancers in Austria;Pinter;Liver Int.,2014

2. Trends in the incidence and management of biliary tract cancer: a French population-based study;Lepage;J. Hepatol.,2011

3. Cholangiocarcinoma;Khan;Lancet,2005

4. Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors;Shimada;Hepatogastroenterology,1996

5. Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma;Hou;Lab. Invest.,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Atractylodin and β-Eudesmol on P-glycoprotein and Caco-2 Cells Permeability;Phytomedicine Plus;2024-07

2. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives;Expert Review of Clinical Pharmacology;2024-03-15

3. α-Ketoglutarate supplementation and NAD+ modulation enhance metabolic rewiring and radiosensitization in SLC25A1 inhibited cancer cells;Cell Death Discovery;2024-01-15

4. Mechanism of PARP inhibitor resistance and potential overcoming strategies;Genes & Diseases;2024-01

5. Optimization of Metabolomics Pretreatment Method of Cholangiocarcinoma Cells Based on Ultrahigh Performance Liquid Chromatography Coupled with Mass Spectrometry;2024